DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS Trademark

Trademark Overview


On Friday, September 13, 2019, a trademark application was filed for DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS with the United States Patent and Trademark Office. The USPTO has given the DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark a serial number of 88615918. The federal status of this trademark filing is REGISTERED as of Tuesday, July 13, 2021. This trademark is owned by Gilead Sciences Ireland UC. The DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Anti-viral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment of immune dysfunction; pharmaceutical preparations for the treatment and prevention of human immunodeficiency virus infection; all of the foregoing containing emtricitabine and tenofovir alafenamide

Information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; providing medical information and advisory services regarding HIV infection
descovy emtricitabine 200 mg / tenofovir alafenamide 25mg tablets for prep pre-exposure prophylaxis

General Information


Serial Number88615918
Word MarkDESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Filing DateFriday, September 13, 2019
Status700 - REGISTERED
Status DateTuesday, July 13, 2021
Registration Number6414007
Registration DateTuesday, July 13, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 3, 2020

Trademark Statements


Indication of Colors claimedThe color(s) blue, light blue, and black is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS"
Description of MarkThe mark consists of a blue diamond with an incomplete light blue diamond below it along with the word "DESCOVY" in blue to the right and the words "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS" in black beneath "DESCOVY". Appearing below is the stylized wording "FOR PREP PRE-EXPOSURE PROPHYLAXIS" with the wording "FOR" and "PRE-EXPOSURE PROPHYLAXIS" in light blue, and the word "PREP" contained within a blue oblong shaped pill design. All instances of the color white in the mark represent background and/or transparent areas only and are not features of the mark.
Goods and ServicesAnti-viral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment of immune dysfunction; pharmaceutical preparations for the treatment and prevention of human immunodeficiency virus infection; all of the foregoing containing emtricitabine and tenofovir alafenamide
Goods and ServicesInformation and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; providing medical information and advisory services regarding HIV infection
Pseudo MarkDESCOVY EMTRICITABINE TWO HUNDRED MILLIGRAMS / TENOFOVIR ALAFENAMIDE TWENTY FIVE MILLIGRAMS TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 23, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Tuesday, July 13, 2021REGISTERED-PRINCIPAL REGISTER
Friday, June 4, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, May 3, 2021NOTICE OF ALLOWANCE CANCELLED
Friday, June 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 3, 2021TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 29, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 14, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 29, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 25, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, September 22, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 22, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, September 22, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 22, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, September 22, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 1, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 26, 2020ASSIGNED TO LIE
Thursday, August 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 6, 2020NON-FINAL ACTION E-MAILED
Monday, April 6, 2020NON-FINAL ACTION WRITTEN
Friday, March 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 21, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 21, 2019NON-FINAL ACTION E-MAILED
Saturday, December 21, 2019NON-FINAL ACTION WRITTEN
Saturday, December 14, 2019ASSIGNED TO EXAMINER
Tuesday, September 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 17, 2019NEW APPLICATION ENTERED IN TRAM